Clinical Trial Results: What the Data Shows Semaglutide has been evaluated in the STEP (Semaglutide Treatment Effect in People with obesity) trial program, which included four major studies of semaglutide 2.4 mg weekly across different patient populations, including adults with obesity, adults with type 2 diabetes, and adults receiving intensive behavioral support alongside the medication
From better heart health to better sleep quality, weight loss is known to improve a wide range of health outcomes, and when applicants qualify for our studies, they are opening the door to greater clarity about their health profile and the potential benefits from investigational treatments. Clinical trials are a key component of treatment development and medical advances
To determine the appropriate Calorie target to maintain weight using this calculator, we need to know your age, height, weight, and activity level
A: Typically, candidates are individuals with type 2 diabetes or those with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition, including hypertension
Thats completely normal
